Celecoxib Add-On Therapy Compared to Haloperidol Alone in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Phase 4
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT138809201457N6
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
DSM-IV-TR criteria for schizophrenia, Information consent of patients and their tutor Exclusion criteria: Infectious diseases, inflammatory diseases, Anti-inflammatory drug consumption Inflammatory
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Schizophrenia symptoms. Timepoint: weekly. Method of measurement: Positive and Negative Syndrome Scale (PANSS).
- Secondary Outcome Measures
Name Time Method